Peranzoni E - Search Results

1

miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis.

Sonda N, Simonato F, Peranzoni E, Calì B, Bortoluzzi S, Bisognin A, Wang E, Marincola FM, Naldini L, Gentner B, Trautwein C, Sackett SD, Zanovello P, Molon B, Bronte V. Sonda N, et al. Among authors: peranzoni e. Immunity. 2013 Jun 27;38(6):1236-49. doi: 10.1016/j.immuni.2013.06.004. Immunity. 2013. PMID: 23809164 Free article.

2

Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.

Bronte V, Cingarlini S, Marigo I, De Santo C, Gallina G, Dolcetti L, Ugel S, Peranzoni E, Mandruzzato S, Zanovello P. Bronte V, et al. Among authors: peranzoni e. Immunol Invest. 2006;35(3-4):327-57. doi: 10.1080/08820130600754994. Immunol Invest. 2006. PMID: 16916757 Review.

3

Role of arginine metabolism in immunity and immunopathology.

Peranzoni E, Marigo I, Dolcetti L, Ugel S, Sonda N, Taschin E, Mantelli B, Bronte V, Zanovello P. Peranzoni E, et al. Immunobiology. 2007;212(9-10):795-812. doi: 10.1016/j.imbio.2007.09.008. Epub 2007 Nov 14. Immunobiology. 2007. PMID: 18086380 Free article. Review.

4

Myeloid-derived suppressor cell role in tumor-related inflammation.

Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V. Dolcetti L, et al. Among authors: peranzoni e. Cancer Lett. 2008 Aug 28;267(2):216-25. doi: 10.1016/j.canlet.2008.03.012. Epub 2008 Apr 22. Cancer Lett. 2008. PMID: 18433992 Review.

5

Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes.

Ugel S, Scarselli E, Iezzi M, Mennuni C, Pannellini T, Calvaruso F, Cipriani B, De Palma R, Ricci-Vitiani L, Peranzoni E, Musiani P, Zanovello P, Bronte V. Ugel S, et al. Among authors: peranzoni e. Blood. 2010 Feb 18;115(7):1374-84. doi: 10.1182/blood-2009-07-233270. Epub 2009 Nov 10. Blood. 2010. PMID: 19903903 Free article.

6

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, Geilich M, Winkels G, Traggiai E, Casati A, Grassi F, Bronte V. Dolcetti L, et al. Among authors: peranzoni e. Eur J Immunol. 2010 Jan;40(1):22-35. doi: 10.1002/eji.200939903. Eur J Immunol. 2010. PMID: 19941314 Free article.

7

Myeloid-derived suppressor cell heterogeneity and subset definition.

Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V. Peranzoni E, et al. Curr Opin Immunol. 2010 Apr;22(2):238-44. doi: 10.1016/j.coi.2010.01.021. Epub 2010 Feb 17. Curr Opin Immunol. 2010. PMID: 20171075 Review.

8

Measurement of myeloid cell immune suppressive activity.

Dolcetti L, Peranzoni E, Bronte V. Dolcetti L, et al. Among authors: peranzoni e. Curr Protoc Immunol. 2010 Nov;Chapter 14:Unit 14.17. doi: 10.1002/0471142735.im1417s91. Curr Protoc Immunol. 2010. PMID: 21053303

9

Myeloid cell diversification and complexity: an old concept with new turns in oncology.

Chioda M, Peranzoni E, Desantis G, Papalini F, Falisi E, Solito S, Mandruzzato S, Bronte V. Chioda M, et al. Among authors: peranzoni e. Cancer Metastasis Rev. 2011 Mar;30(1):27-43. doi: 10.1007/s10555-011-9268-1. Cancer Metastasis Rev. 2011. PMID: 21267772 Review.

10

Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.

Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, Ochando JC, Cabrelle A, Mandruzzato S, Bronte V. Ugel S, et al. Among authors: peranzoni e. Cell Rep. 2012 Sep 27;2(3):628-39. doi: 10.1016/j.celrep.2012.08.006. Epub 2012 Sep 6. Cell Rep. 2012. PMID: 22959433 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters